JCL Roundtable. Making prevention a priority

Anandita Agarwala, Anne C. Goldberg, Christie M. Ballantyne, John R. Guyton

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Clinical lipidology belongs par excellence to the preventive mode of medical practice. This Roundtable brings two long-time advocates of cardiometabolic prevention and a newly minted preventive cardiologist into a discussion that expands their recent JCL editorial on this topic. Atherosclerosis is a single disease process that leads to approximately 25% of deaths in economically advanced nations and a growing fraction of mortality and morbidity in nations with developing and emerging economies. Our discussants suggest that at least 75% of atherosclerotic cardiovascular disease can be prevented. Diet and lifestyle including physical activity are the cornerstones for this effort. Public and private choices about diet-lifestyle are influenced by economics, education (especially in childhood), inequities, technology, misinformation, and trust. Lipid clinics perform well with pharmacologic treatment of lipid disorders and increasingly give attention to hypertension, obesity, and diabetes as needed. Cardiometabolic prevention in the clinic works best through provider teams. Business considerations and exemplary programs are highlighted.

Original languageEnglish
Pages (from-to)530-537
Number of pages8
JournalJournal of Clinical Lipidology
Issue number4
StatePublished - Jul 1 2021


Dive into the research topics of 'JCL Roundtable. Making prevention a priority'. Together they form a unique fingerprint.

Cite this